Cevimeline: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Cevimeline. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Headache | 20.1% |
| Excessive sweating | 18.7% |
| Nausea | 13.8% |
| Sinusitis | 12.3% |
| Upper respiratory tract infection | 11.4% |
| Rhinitis | 11.2% |
| Diarrhea | 10.3% |
| Dyspepsia | 8.5% |
| Abdominal pain | 7.6% |
| Dizziness | 7.3% |
| Urinary tract infection | 6.1% |
| Coughing | 6.1% |
| Rash | 6% |
| Pharyngitis | 5.4% |
| Vomiting | 4.6% |
| Injury | 4.5% |
| Back pain | 4.5% |
| Conjunctivitis | 4.3% |
| Bronchitis | 4.1% |
| Arthralgia | 3.7% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Cevimeline is indicated for the treatment of symptoms of dry mouth in patients with Sjögren’s Syndrome.
Source: FDA labeling via NIH DailyMed (set 2b429ea7…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.
Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.
Compare lab testing options near you ↗ (affiliate link)